Skip to main content
Cancer Explained
Donate

NewsAwareness

Pancreatic Cancer Awareness Month: Understanding a Difficult Diagnosis with Clarity

Every November, Pancreatic Cancer Awareness Month brings attention to a cancer that is often found late. Here is a calm, honest, NCI-based look at what that means.

By Cancer Explained Editorial TeamPublished Updated

A plain-language summary based on public reporting and trusted sources, linked below.

A female doctor and male doctor review scans together on monitors
A female doctor and male doctor review scans together on monitors — illustrative photograph, not of anyone named in this story.

Please note: this page is educational only — it is not medical advice, and it does not speculate about anyone’s health beyond reliable public reporting. For questions about your own health, talk with your healthcare team.

Why November gets a ribbon

Pancreatic Cancer Awareness Month runs each November. Most awareness months point people toward a test. This one cannot. There is no screening test for pancreatic cancer in people at average risk.

So the month has to do something else. It can teach the symptoms, which are easy to miss and easy to explain away. It can fund research into finding the disease sooner. And it can be honest about where the science stands. That last part is what this page tries to do.

The organ, and the two diseases inside the name

The pancreas is a gland about 6 inches long, shaped like a thin pear on its side. It sits between the stomach and the spine. NCI names its three parts: the head, the body, and the tail.

It has two jobs. It makes juices that break down food. It also makes hormones, insulin among them, that control how the body uses sugar.

Those two jobs sit in two kinds of cell, and each can give rise to a tumor. Exocrine tumors come from the juice-making cells. They are much more common, and they are usually found once they are advanced. Neuroendocrine tumors, also called islet cell tumors, come from the hormone-making cells. They are less common and carry a better outlook.

That split matters. "Pancreatic cancer" in a headline almost always means the exocrine kind. The two are staged and treated differently. Our page on pancreatic cancer goes through both.

Why it is usually found late

NCI is direct about this. Early pancreatic cancer often causes no signs at all. When signs do come, they look like many milder things.

The pancreas also sits deep in the abdomen, behind other organs. A doctor cannot feel a tumor there during a routine exam. And there is no blood test or scan recommended for people without symptoms.

Put those together and you get the pattern the statistics show. Just 15 percent of cases are found while the cancer is still confined to the pancreas. Fifty-one percent are already distant, meaning the cancer has spread to other organs.

Symptoms that should not wait

NCI lists these as the signs that appear as the cancer grows. Any of them can have a harmless cause. All of them are worth a doctor's visit if they persist.

  • Jaundice, meaning yellowing of the skin and the whites of the eyes
  • Light-colored stools
  • Dark urine
  • Pain in the upper or middle abdomen and back
  • Weight loss for no known reason
  • Loss of appetite
  • Fatigue

Jaundice with dark urine and pale stools is the combination to act on quickly. It suggests something is blocking the bile duct, and it needs to be looked at within days, not months.

New diabetes in an adult over 50 who is also losing weight is worth raising too. NCI lists a personal history of diabetes among the risk factors for this cancer.

What raises the risk

NCI names smoking, excess body weight, and a personal history of diabetes or long-standing pancreatitis. Pancreatitis means inflammation of the pancreas.

Family history counts as well: pancreatic cancer or pancreatitis in close relatives. So do several inherited conditions, including Lynch syndrome, Peutz-Jeghers syndrome, hereditary breast and ovarian cancer syndrome, familial atypical multiple mole melanoma, and ataxia-telangiectasia.

Having a risk factor does not mean a person will get this cancer. Many people with several never do, and many with none still do. Smoking is the one on the list that can be changed outright.

How it is worked up and treated

Diagnosis uses blood chemistry, tumor marker tests such as CA 19-9 and CEA, and imaging with CT, MRI, or ultrasound. Tissue is taken for a diagnosis where it can be.

Surgery is the only route to removing the tumor, and it is possible for a minority of people. NCI describes three operations. The Whipple procedure takes out the head of the pancreas, the gallbladder, part of the stomach, part of the small intestine, and the bile duct. A distal pancreatectomy takes the body and tail. A total pancreatectomy takes the whole gland.

Chemotherapy is given by vein or by mouth so it reaches the whole body. NCI lists capecitabine, fluorouracil, gemcitabine, irinotecan, nanoliposomal irinotecan, leucovorin, and oxaliplatin, often in combination. Chemoradiation pairs chemotherapy with radiation. Targeted therapy is used in a small number of cases. Our page on chemotherapy explains how cycles work.

When the tumor cannot be removed, surgery still has a role in relieving symptoms. A biliary bypass reroutes bile around a blockage. A stent can hold the duct open. These operations do not treat the cancer, but they make people feel better.

The numbers, and their limits

The American Cancer Society projects 67,530 new cases and 52,740 deaths in the United States in 2026, a figure SEER carries on its pancreas page. Five-year relative survival across all stages was 13.7 percent for cases from 2016 to 2022.

By stage, that figure was 43.6 percent for localized disease, 17.0 percent for regional disease, and 3.4 percent for distant disease. About 1.7 percent of people are diagnosed with pancreatic cancer at some point in life.

The gap between 43.6 and 3.4 is the whole argument for taking symptoms seriously.

What this does not mean

These figures cover people diagnosed years ago and treated with what was available then. They average across ages, health, tumor types, and treatments. They describe a group, not a reader.

Awareness also cannot substitute for a test that does not exist. NCI states plainly that it has no evidence-based information on screening for pancreatic cancer, and none on preventing it. Anyone selling an early-detection package for the general public is ahead of the evidence.

What awareness can do is shorten the time between a first symptom and a first appointment. On these numbers, that is not a small thing.

Sources

How this article was prepared

An AI-assisted editorial system helped prepare this page. No named medical reviewer has reviewed it unless one is listed.

The National Cancer Information Foundation publishes Cancer Explained. This page is for learning. It is not medical advice and does not suggest a test or treatment.

See an error, old source, or unclear wording? Tell us.

Know someone who needs this?

Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.

Email itText itWhatsApp

Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.

Put the story in context

Prevention, possible warning signs, screening, and diagnosis

This story relates to Pancreatic cancer. The information below is general: it does not reveal anything else about a public person’s health, and not every point applies to every cancer. Personal advice depends on age, symptoms, family history, exposures, and medical history.

  • Prevention and risk reduction

    Not every cancer can be prevented. Avoiding tobacco, protecting skin from ultraviolet radiation, limiting alcohol, staying active, and receiving recommended HPV or hepatitis B vaccination can lower the risk of certain cancers. A risk factor is not a prediction or a cause in one individual.

    NCI prevention information

  • Symptoms and possible early signs

    Possible signs vary and are often caused by conditions other than cancer. Changes worth discussing include a new lump, unexplained bleeding or weight loss, a persistent cough, lasting bowel or bladder changes, a changing skin spot, or symptoms that persist or worsen. Some early cancers cause no symptoms.

    NCI signs and symptoms

  • Screening and early detection

    Screening looks for certain cancers before symptoms begin. Recommended tests exist only for some cancers and depend on age and risk. Screening can have benefits and harms; it is not the same as evaluating a new symptom, and there is no single routine scan or blood test that reliably screens for every cancer.

    NCI cancer screening information

  • How cancer is diagnosed

    Diagnosis may involve a history and exam, imaging, laboratory tests, and often a biopsy. Pathology can identify the cancer type and may test biomarkers that guide treatment. Symptoms, screening results, tumor markers, or online stories alone cannot confirm cancer.

    NCI diagnosis information

A public story may encourage questions, but it should not be used to estimate your risk or choose testing. Contact a healthcare professional about a persistent or concerning change. Seek urgent care for severe or rapidly worsening symptoms.

Go deeper with NCI